Total Payments
$89,431
2024 Payments
$56,966
Companies
23
Transactions
164
Payment Breakdown by Category
Other$69,130 (77.3%)
Travel$12,142 (13.6%)
Food & Beverage$5,591 (6.3%)
Consulting$2,545 (2.8%)
Education$23.84 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $55,030 | 20 | 61.5% |
| Honoraria | $14,100 | 12 | 15.8% |
| Travel and Lodging | $12,142 | 33 | 13.6% |
| Food and Beverage | $5,591 | 94 | 6.3% |
| Consulting Fee | $2,545 | 4 | 2.8% |
| Education | $23.84 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $55,330 | 59 | $0 (2024) |
| Rhythm Pharmaceuticals, Inc. | $16,846 | 26 | $0 (2024) |
| Ascendis Pharma Inc | $9,895 | 13 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $3,911 | 6 | $0 (2020) |
| Tandem Diabetes Care, Inc. | $649.95 | 5 | $0 (2018) |
| Azurity Pharmaceuticals, Inc. | $460.50 | 2 | $0 (2024) |
| MannKind Corporation | $364.87 | 2 | $0 (2023) |
| ABBVIE INC. | $282.32 | 16 | $0 (2024) |
| Dexcom, Inc. | $239.36 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $214.94 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56,966 | 68 | Novo Nordisk Inc ($31,883) |
| 2023 | $24,963 | 36 | Novo Nordisk Inc ($21,779) |
| 2022 | $1,217 | 7 | Novo Nordisk Inc ($1,135) |
| 2021 | $165.63 | 4 | Novo Nordisk Inc ($123.12) |
| 2020 | $3,896 | 5 | Arbor Pharmaceuticals, Inc. ($3,896) |
| 2019 | $359.23 | 4 | Ultragenyx Pharmaceutical Inc. ($185.74) |
| 2018 | $655.54 | 11 | Novo Nordisk Inc ($302.95) |
| 2017 | $1,208 | 29 | Tandem Diabetes Care, Inc. ($582.74) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Honoraria | Cash or cash equivalent | $900.00 | General |
| Category: Genetic Disease | ||||||
| 12/11/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Travel and Lodging | Cash or cash equivalent | $313.56 | General |
| Category: Genetic Disease | ||||||
| 11/28/2024 | Azurity Pharmaceuticals, Inc. | TRIPTODUR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $375.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/21/2024 | Rhythm Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $1,800.00 | General |
| 11/21/2024 | Rhythm Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $414.24 | General |
| 11/21/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Growth Hormone | ||||||
| 11/21/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Honoraria | Cash or cash equivalent | $600.00 | General |
| Category: Genetic Disease | ||||||
| 11/11/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Food and Beverage | In-kind items and services | $100.68 | General |
| Category: Genetic Disease | ||||||
| 11/04/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Honoraria | Cash or cash equivalent | $900.00 | General |
| Category: Genetic Disease | ||||||
| 11/04/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Travel and Lodging | Cash or cash equivalent | $309.16 | General |
| Category: Genetic Disease | ||||||
| 11/04/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Travel and Lodging | Cash or cash equivalent | $63.87 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Honoraria | Cash or cash equivalent | $1,200.00 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Honoraria | Cash or cash equivalent | $900.00 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Travel and Lodging | Cash or cash equivalent | $148.63 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Food and Beverage | In-kind items and services | $90.24 | General |
| Category: Genetic Disease | ||||||
| 10/17/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,208.00 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Rhythm Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 10/14/2024 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $159.50 | General |
| Category: Growth Hormone | ||||||
| 10/10/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Travel and Lodging | Cash or cash equivalent | $148.41 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 09/29/2024 | Rhythm Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $2,100.00 | General |
| 09/29/2024 | Rhythm Pharmaceuticals, Inc. | — | Travel and Lodging | Cash or cash equivalent | $238.87 | General |
| 09/19/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Travel and Lodging | Cash or cash equivalent | $730.77 | General |
| Category: Endocrinology | ||||||
About Dr. Jose Gamez-Godoy, M.D
Dr. Jose Gamez-Godoy, M.D is a Pediatric Endocrinology healthcare provider based in Edinburg, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1992952758.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Gamez-Godoy, M.D has received a total of $89,431 in payments from pharmaceutical and medical device companies, with $56,966 received in 2024. These payments were reported across 164 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($55,030).
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Edinburg, TX
- Active Since 08/24/2008
- Last Updated 03/28/2023
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1992952758
Products in Payments
- Sogroya (Biological) $53,662
- Skytrofa (Drug) $9,711
- IMCIVREE (Drug) $9,438
- Triptodur (Drug) $3,997
- Imcivree (Drug) $1,230
- Norditropin (Biological) $1,095
- t-slim insulin pump (Device) $649.95
- TRIPTODUR (Drug) $375.00
- AFREZZA (Drug) $364.87
- Synthroid (Drug) $201.97
- Dexcom G6 Transmitter (Medical Supply) $194.73
- CRYSVITA (Drug) $185.74
- SKYTROFA (Drug) $183.98
- Norditropin (Drug) $163.21
- Macrilen (Biological) $162.68
- Omnipod (Device) $154.22
- VRAYLAR (Drug) $131.68
- GENOTROPIN (Drug) $129.31
- LOKELMA (Drug) $125.00
- FreeStyle Libre Pro (Device) $116.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.